Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies.
about
Rasburicase (Elitek): a novel agent for tumor lysis syndrome.Management of tumor lysis syndrome in adults.Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).The clinical management of tumour lysis syndrome in haematological malignancies.Montmorillonite adsorbs uric acid and increases the excretion of uric acid from the intestinal tract in mice.
P2860
Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recombinant urate oxidase for ...... rome in lymphoid malignancies.
@ast
Recombinant urate oxidase for ...... rome in lymphoid malignancies.
@en
type
label
Recombinant urate oxidase for ...... rome in lymphoid malignancies.
@ast
Recombinant urate oxidase for ...... rome in lymphoid malignancies.
@en
prefLabel
Recombinant urate oxidase for ...... rome in lymphoid malignancies.
@ast
Recombinant urate oxidase for ...... rome in lymphoid malignancies.
@en
P356
P1476
Recombinant urate oxidase for ...... rome in lymphoid malignancies.
@en
P2093
Raul C Ribeiro
P304
P356
10.3816/CLM.2003.N.003
P577
2003-03-01T00:00:00Z